Revance Therapeutics shares owned by Perfromance Wealth Partners
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Perfromance Wealth Partners
from 13F filings
Historical chart of Perfromance Wealth Partners investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Perfromance Wealth Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Revance Therapeutics by Perfromance Wealth Partners
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $81k | 17k | 4.92 |
2023-09-30 | $212k | 19k | 11.47 |
2023-06-30 | $457k | 19k | 24.72 |
2023-03-31 | $499k | 16k | 32.21 |
2022-12-31 | $240k | 13k | 18.46 |
2022-09-30 | $351k | 13k | 27.00 |
2022-06-30 | $180k | 13k | 13.85 |
2022-03-31 | $254k | 13k | 19.54 |
2021-12-31 | $212k | 13k | 16.31 |
More positions owned by Perfromance Wealth Partners
View all positions for Perfromance Wealth Partners